Teams of the Alliance

This trans-NIH scientific consortium is comprised of 10 Tumor Glycomics Laboratories supported through the National Cancer Institute (NCI), the Consortium for Functional Glycomics and the Glycomics and Glycotechnology Resource Centers of the National Institute of General Medical Sciences (NIGMS), and the Early Detection Research Network supported through NCI.

The 10 teams of the Alliance fall into one of two categories: (1) Translational Tumor Glycomics Laboratories, and (2) Biological Tumor Glycomics Laboratories. 

Translational Tumor Glycomics Laboratories

• Karen Abbott, Ph.D.
  University of Oklahoma Health Sciences Center
   
• Brian Haab, Ph.D. / Randy Brand, M.D.
  Van Andel Research Institute / University of Pittsburgh
   
• David M. Lubman, Ph.D. / Yehia Mechref, Ph.D.
  University of Michigan at Ann Arbor / Texas Tech University
   
• Anand Mehta, DPh / Richard Drake, Ph.D. / Amit Singal, M.D. / Yujin Hoshida, M.D., Ph.D.
  Medical University of South Carolina / The University of Texas Southwestern
   
• Sharon Pitteri, Ph.D. / Carolyn Bertozzi, Ph.D. / James Brooks, M.D.
  Stanford University

Biological Tumor Glycomics Laboratories

• Susan L. Bellis, Ph.D. / Lance Wells, Ph.D.
  University of Alabama at Birmingham / University of Georgia
   
• Charles Dimitroff, Ph.D., M.S. / Stuart Haslam, Ph.D.
  Florida International University / Imperial College, London
   
• Mauricio Reginato, Ph.D. / Lauren Ball, Ph.D.
  Drexel University / Medical University of South Carolina
   
• Robert Sackstein, M.D., Ph.D.
  Florida International University
   
• Lianchun Wang, M.D. / Houjian Cai, Ph.D.
  University of South Florida / University of Georgia

Administration

• NCI Division of Cancer Prevention